-
DAAN and GC Cell agree on CAR T, CAR-NK therapies
Apr 22 2025 -
Exclusive: George Church startup will study long-lived animals, humans to find life-extending genes
Apr 22 2025 -
Rona Therapeutics Announces NMPA Approval of IND Application for RN1871, a Novel Angiotensinogen (AGT)-Targeting siRNA Drug for Hypertension
Apr 21 2025 -
FDA grants breakthrough status to uniQure’s Huntington’s therapy
Apr 21 2025 -
Exosomes: What They Do and Who’s Doing What
Apr 21 2025 -
New Strategy Enhances CRISPR Editing Efficiency for Therapeutic Use
Apr 18 2025 -
uniQure’s AMT-130 Receives FDA Breakthrough Therapy Designation for Huntington’s Disease
Apr 17 2025 -
Rare Diseases in Malaysia: An Overlooked Crisis Affecting One Million
Apr 17 2025 -
French Biotech Brink Therapeutics Secures €3.5M to Pioneer Next-Generation Gene Editing with Recombinases
Apr 17 2025